2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1154881613 DO
Verify on CMS →

Kate Cappetta, DO

Endocrinology, Diabetes & Metabolism Physician in Boston, Massachusetts.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
602
Medicare Part D claims · 106 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
55%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Kate Cappetta, DO filed 602 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Boston, Massachusetts, prescribing 55% generic.

602
Part D claims, 2024
55%
generic prescribing
Likely
board-certified (heuristic)
≥68th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Kate Cappetta, DO

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1154881613), first enumerated 03/21/2019.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 602 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Kate Cappetta, DO's individual license status. Verify directly with the state medical board.

    Source: BORIM annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1154881613 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1154881613
  • ENUM-RECENT 2019
  • TAX-MID 8K Endocrinology, Diabetes
  • RX-LIGHT 602
  • BOOK-THIN 373 in Massachusetts
  • PHOTO-ENUM Corina Nava Suarez · 2019

Kate Cappetta, DO's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

602 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). This entry sits in this band. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Kate Cappetta, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Kate Cappetta, DO?

Quality data not reported

NPI registry status

Active

Issued 03/21/2019

NPI 1154881613

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

602 78% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

Specialty distribution in Massachusetts

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers

Massachusetts providers
Mental Health Counselor8.3%Clinical Social Worker7.7%Student in an Organized Heal…6.2%Behavior Technician5.3%Counselor4.3%Internal Medicine Physician3.6%Endocrinology, Diabetes & Me…0.2%
Largest specialties in Massachusetts (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

800 WASHINGTON ST # 268
Boston, MA 02111

Provider Details

NPI 1154881613
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials DO
Gender Female
NPI Issued 03/21/2019

Hospital and facility affiliations

Facilities where Kate Cappetta, DO bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Core Physicians LLC
Derry, NH
Lahey Clinic Inc
Peabody, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - Massachusetts BORIM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Kate Cappetta, DO. To verify Kate Cappetta, DO's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Kate Cappetta, DO - brand share 36.0%
Endocrinology, Diabetes & Metabolism Physician average

36% brand-name claims vs 55% generic, on 602 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

602
Total Claims
$264K
Total Drug Cost
106
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,184.733
Total Day Supply
34,875
Brand vs Generic
36% brand / 55% generic
Brand Drug Cost
$250K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
2.01
Gender Split
55% female / 45% male
Age Distribution
<65: 19, 65-74: 54, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Kate Cappetta, DO prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Levothyroxine Sodium
70
Trulicity
Dulaglutide
38
Alendronate Sodium
33
Pioglitazone Hcl
28
Metformin Hcl
25
Lantus Solostar
Insulin Glargine,hum.Rec.Anlog
22
Hydrocortisone
21
Ozempic
Semaglutide
21
Testosterone
17
Methimazole
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Kate Cappetta, DO fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Kate Cappetta, DO's 602 claims are below the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Cappetta, both outside Massachusetts so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2019)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Cappetta.

One of 373 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Massachusetts, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Kate Cappetta, DO's specialty?
Kate Cappetta, DO specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Boston, Massachusetts. Credentials: DO.
How much does Kate Cappetta, DO prescribe under Medicare Part D?
In 2024, Kate Cappetta, DO wrote 602 Medicare Part D claims totaling $264K in drug costs for 106 beneficiaries.
Where is Kate Cappetta, DO located?
Kate Cappetta, DO is located at 800 WASHINGTON ST # 268, Boston, MA, 02111. Phone: (617) 636-5000.
What is Kate Cappetta, DO's NPI number?
Kate Cappetta, DO's National Provider Identifier (NPI) is 1154881613, issued on 03/21/2019.
Does Kate Cappetta, DO prescribe more brand-name or generic drugs?
Kate Cappetta, DO's prescribing is 36% brand-name and 55% generic drugs by claim count, with $250K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Kate Cappetta, DO prescribe most often?
Based on 2024 Medicare Part D data, Kate Cappetta, DO's most frequently prescribed drugs include Levothyroxine Sodium, Trulicity, Alendronate Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kate Cappetta, DO accept Medicare?
Kate Cappetta, DO appears in CMS Medicare data with 602 Part D claims and 106 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kate Cappetta, DO's credentials?
Kate Cappetta, DO's NPI is 1154881613 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.